Lista de obras -

Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology?

scientific article published on May 2009

Age-of-diagnosis dependent ileal immune intensification and reduced alpha-defensin in older versus younger pediatric Crohn Disease patients despite already established dysbiosis

artículo científico publicado en 2019

Analysis of Using the Total White Blood Cell Count to Define Severe New Onset Ulcerative Colitis in Children

artículo científico publicado en 2020

Appraisal of the pediatric ulcerative colitis activity index (PUCAI)

artículo científico publicado en 2009

Association Between Plasma Level of Collagen Type III alpha 1 Chain and Development of Strictures in Pediatric Patients With Crohn's Disease

artículo científico publicado en 2018

Blood-Derived DNA Methylation Signatures of Crohn's Disease and Severity of Intestinal Inflammation

artículo científico publicado en 2019

C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis

artículo científico publicado en 2011

Characterization of Stool Virome in Children Newly Diagnosed With Moderate to Severe Ulcerative Colitis

artículo científico publicado en 2019

Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study

scientific article published on 29 March 2019

Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course

article

Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN.

artículo científico publicado en 2011

Corrigendum. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature

artículo científico publicado en 2015

Corticosteroid Therapy in the Age of Infliximab: Acute and 1-Year Outcomes in Newly Diagnosed Children With Crohn’s Disease

artículo científico publicado en 2006

Course and Treatment of Perianal Disease in Children Newly Diagnosed with Crohnʼs Disease

artículo científico publicado en 2009

Dissecting Allele Architecture of Early Onset IBD Using High-Density Genotyping

artículo científico publicado en 2015

Effect of early immunomodulator use in moderate to severe pediatric Crohn disease

artículo científico publicado en 2008

Enhanced Contribution of HLA in Pediatric Onset Ulcerative Colitis

artículo científico publicado en 2018

Evaluation of the Pediatric Crohn Disease Activity Index: A Prospective Multicenter Experience

article

Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity

artículo científico publicado en 2010

Factors That Determine Risk for Surgery in Pediatric Patients With Crohn's Disease

artículo científico publicado en 2010

Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study

artículo científico publicado en 2017

Free and Bioavailable 25-Hydroxyvitamin D Concentrations are Associated With Disease Activity in Pediatric Patients With Newly Diagnosed Treatment Naïve Ulcerative Colitis.

artículo científico publicado en 2018

Gene expression changes associated with resistance to intravenous corticosteroid therapy in children with severe ulcerative colitis

artículo científico publicado en 2010

Glucocorticoid bioactivity does not predict response to steroid therapy in severe pediatric ulcerative colitis

artículo científico publicado en 2010

Growth Abnormalities Persist in Newly Diagnosed Children With Crohn Disease Despite Current Treatment Paradigms

artículo científico publicado en 2009

Health-related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease

article

Histologic Correlates of Clinical and Endoscopic Severity in Children Newly Diagnosed With Ulcerative Colitis.

artículo científico publicado en 2017

Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease

artículo científico publicado en 2013

Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative Colitis ⬇️

artículo científico publicado el 8 de diciembre de 2011

Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children

artículo científico publicado en 2006

Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease

artículo científico publicado en 2017

Infliximab therapy in children with concurrent perianal Crohn disease: observations from REACH

artículo científico publicado en 2009

Laboratory values for children with newly diagnosed inflammatory bowel disease

artículo científico publicado en 2007

Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease.

artículo científico publicado en 2018

Long-term outcome of maintenance infliximab therapy in children with Crohnʼs disease

artículo científico publicado en 2009

Microbiota-sensitive epigenetic signature predicts inflammation in Crohn's disease

Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients

artículo científico publicado en 2017

Mucosal Inflammatory and Wound Healing Gene Programs Reveal Targets for Stricturing Behavior in Pediatric Crohn's Disease

artículo científico publicado en 2020

Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature

artículo científico publicado en 2014

Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study

artículo científico publicado en 2017

Real-time tool to display the predicted disease course and treatment response for children with Crohn's disease

artículo científico publicado en 2010

Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's disease

artículo científico publicado en 2009

Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension ⬇️

artículo científico publicado el 18 de enero de 2011

Serologic Reactivity Reflects Clinical Expression of Ulcerative Colitis in Children

scientific article published on 01 May 2018

Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response

artículo científico publicado en 2010

The Effect of Early-Life Environmental Exposures on Disease Phenotype and Clinical Course of Crohn's Disease in Children

scientific article published on 28 September 2018

The Natural History of Corticosteroid Therapy for Ulcerative Colitis in Children

artículo científico publicado en 2006

The treatment-naive microbiome in new-onset Crohn's disease

artículo científico publicado en 2014

Transcriptional risk scores link GWAS to eQTLs and predict complications in Crohn's disease

artículo científico

Transition of the patient with inflammatory bowel disease from pediatric to adult care: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition

artículo científico publicado en 2002

Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response

artículo científico publicado en 2019

Utility of neutrophil Fcγ receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn's disease

artículo científico publicado en 2014

Variation in Care in the Management of Children With Crohn's Disease: Data From a Multicenter Inception Cohort Study

artículo científico publicado en 2019

Lista de obras de

Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology?

Age-of-diagnosis dependent ileal immune intensification and reduced alpha-defensin in older versus younger pediatric Crohn Disease patients despite already established dysbiosis

Analysis of Using the Total White Blood Cell Count to Define Severe New Onset Ulcerative Colitis in Children

Appraisal of the pediatric ulcerative colitis activity index (PUCAI)

Association Between Plasma Level of Collagen Type III alpha 1 Chain and Development of Strictures in Pediatric Patients With Crohn's Disease

Blood-Derived DNA Methylation Signatures of Crohn's Disease and Severity of Intestinal Inflammation

C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis

Characterization of Stool Virome in Children Newly Diagnosed With Moderate to Severe Ulcerative Colitis

Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study

Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course

Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN.

Corrigendum. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature

Corticosteroid Therapy in the Age of Infliximab: Acute and 1-Year Outcomes in Newly Diagnosed Children With Crohn’s Disease

Course and Treatment of Perianal Disease in Children Newly Diagnosed with Crohnʼs Disease

Dissecting Allele Architecture of Early Onset IBD Using High-Density Genotyping

Effect of early immunomodulator use in moderate to severe pediatric Crohn disease

Enhanced Contribution of HLA in Pediatric Onset Ulcerative Colitis

Evaluation of the Pediatric Crohn Disease Activity Index: A Prospective Multicenter Experience

Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity

Factors That Determine Risk for Surgery in Pediatric Patients With Crohn's Disease

Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study

Free and Bioavailable 25-Hydroxyvitamin D Concentrations are Associated With Disease Activity in Pediatric Patients With Newly Diagnosed Treatment Naïve Ulcerative Colitis.

Gene expression changes associated with resistance to intravenous corticosteroid therapy in children with severe ulcerative colitis

Glucocorticoid bioactivity does not predict response to steroid therapy in severe pediatric ulcerative colitis

Growth Abnormalities Persist in Newly Diagnosed Children With Crohn Disease Despite Current Treatment Paradigms

Health-related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease

Histologic Correlates of Clinical and Endoscopic Severity in Children Newly Diagnosed With Ulcerative Colitis.

Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease

Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative Colitis ⬇️

Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children

Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease

Infliximab therapy in children with concurrent perianal Crohn disease: observations from REACH

Laboratory values for children with newly diagnosed inflammatory bowel disease

Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease.

Long-term outcome of maintenance infliximab therapy in children with Crohnʼs disease

Microbiota-sensitive epigenetic signature predicts inflammation in Crohn's disease

Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients

Mucosal Inflammatory and Wound Healing Gene Programs Reveal Targets for Stricturing Behavior in Pediatric Crohn's Disease

Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature

Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study

Real-time tool to display the predicted disease course and treatment response for children with Crohn's disease

Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's disease

Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension ⬇️

Serologic Reactivity Reflects Clinical Expression of Ulcerative Colitis in Children

Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response

The Effect of Early-Life Environmental Exposures on Disease Phenotype and Clinical Course of Crohn's Disease in Children

The Natural History of Corticosteroid Therapy for Ulcerative Colitis in Children

The treatment-naive microbiome in new-onset Crohn's disease

Transcriptional risk scores link GWAS to eQTLs and predict complications in Crohn's disease

Transition of the patient with inflammatory bowel disease from pediatric to adult care: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition

Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response

Utility of neutrophil Fcγ receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn's disease

Variation in Care in the Management of Children With Crohn's Disease: Data From a Multicenter Inception Cohort Study